Lataa...
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
Neuraminidase (NA) immunity leads to decreased viral shedding and reduced severity of influenza disease; however, NA content in influenza vaccines is currently not regulated, resulting in inconsistent quality and quantity of NA that can vary from manufacturer to manufacturer, from year to year, and...
Tallennettuna:
| Julkaisussa: | NPJ Vaccines |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6342948/ https://ncbi.nlm.nih.gov/pubmed/30675394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-019-0099-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|